The 35th Annual Meeting of the Society of Virology (GfV) in Heidelberg: uniting virology research across German-speaking countries
Journal of Virology · 2026
DOI: 10.1128/jvi.01100-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Ralf Bartenschlager und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany. Hauptthemen laut MEDLINE: Virology, Virus Diseases. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The Society of Virology (GfV) is a non-profit association and academic society dedicated to promoting virology across all disciplines in the German-speaking countries of Austria, Germany, and Switzerland. This mission is pursued through a variety of activities, most notably its annual meeting, which provides a stimulating environment—particularly for young scientists and students—to exchange ideas, establish new collaborations, and learn from leading virologists in an informal setting. This year, the GfV held its annual meeting in the picturesque city of Heidelberg, bringing together more than 1,000 participants. The program featured five plenary sessions with distinguished speakers presenting their latest research findings. Topics included virus evolution, the cell biology of viral infection, novel approaches to studying and preventing viral infections with a focus on innovative vaccine strategies, the use of imaging technologies to investigate virus–host interactions, and the development of potent antiviral therapies for chronic viral infections, illustrated by curative therapy of chronic hepatitis C and long-term prevention of HIV-1 infection. The plenary sessions were complemented by 21 parallel workshops covering all areas of virology, as well as several satellite sessions. Many of these were organized by the Young Society of Virology (jGfV), which is dedicated to promoting the next generation of virologists. This report summarizes the presentations delivered by the plenary speakers and provides a brief overview of the activities in the various sessions, including the prize-winning contributions presented at the meeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
- Nanoscale Infection Biology Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
- Research Department Emerging Viruses, Leibniz Institute of Virology, Hamburg, Germany.
- Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
- Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany.
- Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
ORCID-Profile: Ralf Bartenschlager, Christian Sieben, Stephanie Pfaender, Daniel Sauter, Sandra Ciesek
Zitieren
APA
Bartenschlager, R., Sieben, C., Pfaender, S., Sauter, D., Ciesek, S., & Kräusslich, H. G. (2026). The 35th Annual Meeting of the Society of Virology (GfV) in Heidelberg: uniting virology research across German-speaking countries. Journal of Virology. https://doi.org/10.1128/jvi.01100-26
Vancouver
Bartenschlager R, Sieben C, Pfaender S, Sauter D, Ciesek S, Kräusslich HG. The 35th Annual Meeting of the Society of Virology (GfV) in Heidelberg: uniting virology research across German-speaking countries. Journal of Virology. 2026. doi:10.1128/jvi.01100-26
BibTeX
@article{Bartenschlager2026,
author = {Bartenschlager, Ralf and Sieben, Christian and Pfaender, Stephanie and Sauter, Daniel and Ciesek, Sandra and Kräusslich, Hans-Georg},
title = {The 35th Annual Meeting of the Society of Virology (GfV) in Heidelberg: uniting virology research across German-speaking countries},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.01100-26}
}
EUVIMED